News for Healthier Living
Once-Weekly Oral Islatravir Plus Lenacapavir Maintains High Rates of Virologic Suppression in Adults with HIV
A phase 2 randomized study evaluating the efficacy and safety of once-weekly oral islatravir plus lenacapavir (ISL+LEN) in virologically suppressed adults with HIV found that ISL+LEN maintained high rates of virologic suppression through 48 weeks, with no treatment-related grade 3 or greater adverse events or serious adverse events.
December 22, 2025
January 7 2026January 6 2026 - DeepCodon: A Rare-Codon-Aware AI Tool Boosts Protein Expression in E. Coli
- Engineered Probiotics Emerge as Programmable Living Medicines for Complex Diseases
- Renowned UNC Pediatric Biochemical Geneticist Leads First Study on a Novel Treatment for Hunter Syndrome
- High Levels of Chagas Disease Parasite Found in Bugs Near U.S.-Mexico Border
- AI-Powered ECG Analysis Offers Promising Path for Early Detection of Chronic Obstructive Pulmonary Disease, Says Mount Sinai Researchers
- Espervita's EVT0185 Demonstrates Reversal of Metabolic Dysfunction and Liver Fibrosis in Cell Metabolism Publication
- Neutrophil-to-Lymphocyte Ratio May Aid Risk Stratification in Depressive Disorder
- Engineered RNA Sensor Detects and Fights Coronavirus Inside Living Cells
- Advances in Maternal-Fetal and Neonatal Diagnostics Highlighted in Special January Issue of ADLM's Clinical Chemistry Journal
- Can Taking CBD Help People Smoke Less Weed?
- Noninvasive Prenatal Screening Could Prevent Permanent Hearing Loss in Newborns
- U.S. Cuts Recommended Childhood Vaccines
- Nearly 3,000 Pounds of Ground Beef Recalled for Possible E. coli
- U.S. Backs At-Home HPV Testing to Boost Cervical Cancer Screening
- Novo Nordisk Launches Daily Weight-Loss Pill to Expand GLP-1 Access
- Young Adults With IBD Face Insurance, Cost Barriers To Care, Survey Finds
- Fingerprick Blood Test Accurately Assesses Signs of Alzheimer's, Researchers Say
- Food Insecurity, Financial Struggles Increase Children's Risk of Long COVID
- Hormone Drug Helps Fight Hormone-Fueled Breast Cancer, Trial Shows
- Autism Therapy Centers Targeted By Private Equity In U.S., Study Reveals
- Teens' Smartphone Use At School Exceeds An Hour Daily, Tracking App Reveals
- First Patients Enrolled in Groundbreaking Brain Cancer Study at Nationally Recognized Academic Medical Center
- 10 Years Later, First Children's Hospital Los Angeles Patient to Receive CAR T-Cell Therapy Remains Cancer-Free
- A Repurposed Drug Duo Shows Powerful Synergy Against Liver Fibrosis
- CU Scientists Use Ultrasound to Make Tumor Treatment Easier--and Less Risky
January 5 2026January 4 2026January 3 2026January 2 2026January 1 2026December 31 2025December 30 2025December 29 2025December 28 2025December 27 2025December 26 2025December 24 2025
|
|
|
|
|